Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #8, August 2002
A Pennsylvania woman filed what is believed to be the first nationwide class action lawsuit against the manufacturers of Prempro just days after a study designed to evaluate the overall risks and benefits of the drug was abruptly brought to an end.
A motion submitted by the class members of the Baycol Multidisrict Litigation that sought to allow the consolidation of 50 plaintiffs per complaint was denied on grounds that each plaintiff's claims
The decision of a district court to grant summary judgment and preclude the testimony of five expert witnesses in a Parlodel case has been upheld by the U.S. Court of Appeals for the Eleventh Circuit
A pharmacy's motion to dismiss claims in a Propulsid products liability case was granted in part and denied in part by a federal judge who ruled the pharmacy could still be found liable for redhibition claims and misrepresentation
A federal judge dismissed three out of five claims against the manufacturer of Metabolife 356 in a products liability lawsuit ruling the allegations were subsumed
The widow and children of a man who committed suicide approximately 13 days after receiving a prescription for Prozac has filed a lawsuit in federal court alleging the antidepressant caused
Preliminary Injunction Filed to Stop Ads Claiming Paxil <br>Has No Severe Side Effects and Is Non-Habit Forming
Attorneys representing individuals involved in a class action lawsuit against the manufacturer of Paxil filed a preliminary injunction for the removal of television advertisements and promotional materials that state
A Louisiana man's attempt to name individual sales representatives as co-defendants in a Vioxx products liability case was denied by a federal judge who decided
The complaint comes on the heels of a July 9 report from the National Heart, Lung and Blood Institute (NHBLI) that announced it would halt a study investigating the effects of estrogen plus progestin therapy
Issue #7, July 2002